日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural Analysis of Tilvestamab in Complex with AXL

Tilvestamab与AXL复合物的结构分析

Christakou, Eleni; Lopez, Andrea J; Muruganandam, Gopinath; Micklem, David; Lorens, James B; Kursula, Petri

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial

贝莫替尼单药治疗及联合低剂量阿糖胞苷治疗不适合接受强化化疗的急性髓系白血病患者:一项 1b/2a 期试验

Loges, Sonja; Heuser, Michael; Chromik, Jörg; Sutamtewagul, Grerk; Kapp-Schwoerer, Silke; Crugnola, Monica; Di Renzo, Nicola; Lemoli, Roberto; Mattei, Daniele; Fiedler, Walter; Alvarado-Valero, Yesid; Ben-Batalla, Isabel; Waizenegger, Jonas; Rieckmann, Lisa-Marie; Janning, Melanie; Collienne, Maike; Imbusch, Charles D; Beumer, Niklas; Micklem, David; H Nilsson, Linn; Madeleine, Noëlly; McCracken, Nigel; Oliva, Cristina; Gorcea-Carson, Claudia; Gjertsen, Bjørn T

A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients

一项针对复发性、铂耐药性、高级别浆液性卵巢癌 (PROC) 患者的 tilvestamab (BGB149) 的 1b 期多中心剂量递增、安全性和药代动力学研究

Sooi, Kenneth; Tan, Tuan Zea; Kim, Jae-Weon; Lee, Jung Yun; Kim, Byoung-Gie; Micklem, David; Jackson, Akil; Pinato, David J; Gourley, Charlie; Kristeleit, Rebecca; Blagden, Sarah P; Bjorge, Line; Tan, David Shao Peng

Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins

利用高通量细菌表达分泌型scFv-osmY融合蛋白,对抗AXL功能阻断抗体tilvestamab进行互补位定位。

Christakou, Eleni; Kursula, Petri; Micklem, David

AXL-TBK1 driven AKT3 activation promotes metastasis.

AXL-TBK1驱动的AKT3激活促进转移

Arner Emily N, Alzhanova Dina, Westcott Jill M, Hinz Stefan, Tiron Crina Elena, Blø Magnus, Mai Anja, Virtakoivu Reetta, Phinney Natalie, Nord Silje, Aguilera Kristina Y, Rizvi Ali, Toombs Jason E, Reese Tanner C, Fey Vidal, Micklem David, Gausdal Gro, Ivaska Johanna, Lorens James B, Brekken Rolf A

AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

AXL表达反映了肿瘤免疫细胞动态变化,影响接受免疫检查点抑制剂单药治疗的非小细胞肺癌患者的预后。

Rayford, Austin; Gärtner, Fabian; Ramnefjell, Maria P; Lorens, James B; Micklem, David R; Aanerud, Marianne; Engelsen, Agnete S T

Identification of multiple transcription factor genes potentially involved in the development of electrosensory versus mechanosensory lateral line organs

鉴定可能参与电感觉和机械感觉侧线器官发育的多个转录因子基因

Martin Minařík, Melinda S Modrell, J Andrew Gillis, Alexander S Campbell, Isobel Fuller, Rachel Lyne, Gos Micklem, David Gela, Martin Pšenička, Clare V H Baker

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development

体内可溶性AXL的周转和生物分布:对生物标志物开发的影响

Tenstad, Olav; Christakou, Eleni; Hodneland Nilsson, Linn; Gausdal, Gro; Micklem, David; Kursula, Petri; Lorens, James B; Reed, Rolf K

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells

AXL靶向治疗通过扩增TCF1+ CD8 T细胞恢复STK11/LKB1突变型非小细胞肺癌对PD-1阻断的敏感性

Huiyu Li,Zhida Liu,Longchao Liu,Hongyi Zhang,Chuanhui Han,Luc Girard,Hyunsil Park,Anli Zhang,Chunbo Dong,Jianfeng Ye,Austin Rayford,Michael Peyton,Xiaoguang Li,Kimberley Avila,Xuezhi Cao,Shuiqing Hu,Md Maksudul Alam,Esra A Akbay,Luisa M Solis,Carmen Behrens,Sharia Hernandez-Ruiz,Wei Lu,Ignacio Wistuba,John V Heymach,Michael Chisamore,David Micklem,Hani Gabra,Gro Gausdal,James B Lorens,Bo Li,Yang-Xin Fu,John D Minna,Rolf A Brekken

HumanMine: advanced data searching, analysis and cross-species comparison

HumanMine:高级数据搜索、分析和跨物种比较

Lyne, Rachel; Bazaga, Adrián; Butano, Daniela; Contrino, Sergio; Heimbach, Joshua; Hu, Fengyuan; Kalderimis, Alexis; Lyne, Mike; Reierskog, Kevin; Stepan, Radek; Sullivan, Julie; Wise, Archie; Yehudi, Yo; Micklem, Gos